Evidence map›Paper›PMID 20471373›Full record

ArticleBiochemical and biophysical research communications2010

Biochemical and functional analysis of TIR domain containing protein from Brucella melitensis.

Girish K Radhakrishnan, Gary A Splitter

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. ThemicroLife · 2025
    Review
  3. Article
  4. Infection and immunity · 2024
    Article
  5. Cell insight · 2024
    Review
  6. Frontiers in cellular and infection microbiology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. TheThe Journal of biological chemistry · 2017
    Article
  11. AThe EMBO journal · 2017
    Article
  12. Article
  13. Establishment of Chronic Infection: Brucella's Stealth Strategy.Frontiers in cellular and infection microbiology · 2016
    Review
  14. Type IV secretion system of Brucella spp. and its effectors.Frontiers in cellular and infection microbiology · 2015
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Girish K RadhakrishnanDepartment of Pathobiological Sciences, University of Wisconsin-Madison, WI, USA.
Gary A Splitter
University of Wisconsin–Madison · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI KANABROCKI, JOSEPH A. · 2003 to 2013
$87.6M
Brucella epitope recognition by CD8+ T cellsR01AI073558 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI HARMS, JEROME SCOTT, SMITH, JUDITH ANNE · 2008 to 2016
$3.3M
TIR domain containing protein from Brucella melitensisR21AI088038 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI HARMS, JEROME SCOTT · 2010 to 2011
$406k
NIAID NIH HHS 1R01 AI073558NIAID NIH HHS 1U54 AI-057153NIAID NIH HHS R01 AI073558NIAID NIH HHS R21 AI088038NIAID NIH HHS U54 AI057153
6 · The paper itself

Abstract

Toll/interleukin-1 like receptors are evolutionarily conserved proteins in eukaryotes that play crucial role in pathogen recognition and innate immune responses. Brucella are facultative intracellular bacterial pathogens causing brucellosis in animal and human hosts. Brucella behave as a stealthy pathogen by evading the immune recognition or suppressing the TLR signaling cascades. Brucella encode a TIR domain containing protein, TcpB, which suppresses NF-kappaB activation as well as pro-inflammatory cytokine secretion mediated by TLR2 and TLR4 receptors. TcpB targets the TIRAP mediated pathway to suppress TLR signaling. With the objective of detailed characterization, we have over expressed and purified TcpB from Brucella melitensis in native condition. The purified protein exhibited lipid-binding properties and cell permeability. NF-kappaB inhibition property of endogenous TcpB has also been demonstrated. The data provide insight into the mechanism of action of TcpB in the intracellular niche of Brucella.

Indexed as

AnimalsBacterial ProteinsBrucella melitensisCell LineCloning, MolecularEscherichia coliMaltose-Binding ProteinsMiceNF-kappa BPeriplasmic Binding ProteinsPhosphatidylinositolsProtein Structure, TertiaryRecombinant Fusion ProteinsVirulence FactorsBacterial ProteinsMaltose-Binding ProteinsNF-kappa BPeriplasmic Binding ProteinsPhosphatidylinositolsRecombinant Fusion ProteinsTcpB protein, Brucella melitensisVirulence Factors

Identifiers

PMID20471373
PMCPMC2900483
OpenAlexW2073081487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.